Advertisement
Screener

Lumexa Imaging Holdings, Inc. (LMRI) EBITDA

Lumexa Imaging Holdings, Inc. (LMRI) EBITDA

  • 2026-06-30: Basis Reported; EBITDA (m); Operating income $23.04M; Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA (m); Operating income $19.41M; Depreciation and amortization (m).
  • 2025-06-30: Basis Reported; EBITDA (m); Operating income $27.68M; Depreciation and amortization (m).
  • 2025-03-31: Basis Reported; EBITDA (m); Operating income $25.54M; Depreciation and amortization (m).

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported(m)$23.04M(m)$264.16M(m)$9.67M*$32.80M*(m)(m)(m)$3.02M
2026-03-31Reported(m)$19.41M(m)$252.54M(m)$5.31M$2.93M(m)(m)(m)$1.36M
2025-06-30Reported(m)$27.68M(m)$251.40M(m)$4.60M*$2.07M*(m)(m)(m)$4.81M
2025-03-31Reported(m)$25.54M(m)$245.00M(m)$1.00M-$13.96M(m)(m)(m)$3.38M

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit

Similar stocks

Stock NameCountryMarket CapPE Ratio
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
Personalis, Inc. (PSNL)United States$1.769B-13.30
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B